adverse events

Open Access
Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database
MASAKI FUJIWARA, HIROAKI IKESUE, KENTA YAMAOKA, MAYAKO UCHIDA, YOSHIHIRO UESAWA, NOBUYUKI MUROI and TADASHI SHIMIZU

In Vivo January 2025, 39 (1) 396-403; DOI: https://doi.org/10.21873/invivo.13841
Open Access
Impact of Relative Dose Intensity of Enfortumab Vedotin for Advanced Urothelial Carcinoma
NOBUKI FURUBAYASHI, TAKAHITO NEGISHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, HARUMICHI KATSUKI and MOTONOBU NAKAMURA

In Vivo January 2025, 39 (1) 411-418; DOI: https://doi.org/10.21873/invivo.13843
Open Access
Association of Geriatric Nutritional Risk Index With Adverse Event and Treatment Duration in Adjuvant Chemotherapy for Patients With Colorectal Cancer
ATSUYA SHIMIZU, MIYU FUKASAWA, RYOSUKE ENDO, TAKUMI NAKAMURA, SHOGO YAMADA, RYO FUJIBAYASHI, KEN KIKUCHI, MASAOMI TANAKA, ISAO HASEGAWA and HIDEKI SATO

In Vivo January 2024, 38 (1) 453-459; DOI: https://doi.org/10.21873/invivo.13459
Open Access
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
JIRI BLAZEK, PETR HOSEK, KAROLINA HRABCOVA, MONIKA BRATOVA, JURAJ KULTAN, MICHAL HRNCIARIK, MARKETA CERNOVSKA, PETRA ZEMANOVA, JANA KREJCI, LEONA KOUBKOVA, MAREK STASTNY and MARTIN SVATON

In Vivo September 2023, 37 (5) 2229-2236; DOI: https://doi.org/10.21873/invivo.13324
Open Access
Adverse Events in Patients With Esophageal Cancer Treated With Nivolumab in Combination With Radiotherapy
YASUSHI RINO, TORU AOYAMA, YUKIO MAEZAWA, KAZUKI KANO, MIHWA JU, HIROSHI TAMAGAWA, SHO SAWAZAKI, KEISUKE KAZAMA, HARUKA KANAI, TSUTOMU SATO, AYA SAITO and NORIO YUKAWA

In Vivo July 2023, 37 (4) 1760-1764; DOI: https://doi.org/10.21873/invivo.13264
Open Access
The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease
TAKAYUKI MANABE, KUNINORI IWAYAMA, MASAYUKI CHUMA, YOSHIKAZU TASAKI and SEIJI MATSUMOTO

In Vivo May 2023, 37 (3) 1260-1265; DOI: https://doi.org/10.21873/invivo.13203
Open Access
Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia
MAYAKO UCHIDA, ERIKA MOCHIZUKI, SHIGERU ISHIDA, NANA OZAWA, HIROKO YONEMITSU, HIDEKI OCHIAI, HANAE NAKAMURA, TAKEHIRO KAWASHIRI, KOJI KATO, NOBUAKI EGASHIRA, KOICHI AKASHI and ICHIRO IEIRI

In Vivo March 2023, 37 (2) 924-932; DOI: https://doi.org/10.21873/invivo.13164
You have access
Headache Reporting in Oncology Trials Depends on the Demographics of the Study Population
BIRTE J. WOLFF, MATTHAEUS J. WOLFF and JOHANNES E. WOLFF

In Vivo July 2021, 35 (4) 1939-1943; DOI: https://doi.org/10.21873/invivo.12460
You have access
Tolerability and Adverse Events of Adjuvant Chemotherapy for Rectal Cancer in Patients With Diverting Ileostomy
JUN TAKAHASHI, SHINGO TSUJINAKA, RYO MAEMOTO, YASUYUKI MIYAKURA, KOICHI SUZUKI, RINTARO FUKUDA, RYOTARO SAKIO, ERIKA MACHIDA and TOSHIKI RIKIYAMA

In Vivo November 2020, 34 (6) 3399-3406; DOI: https://doi.org/10.21873/invivo.12178
You have access
Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma
TAKAAKI NAKASHIMA, TAKESHI NONOSHITA, HIDENARI HIRATA, KOUJI INOUE, AKIRA NAGASHIMA, TADAMASA YOSHITAKE, KAORI ASAI and YOSHIYUKI SHIOYAMA

In Vivo January 2020, 34 (1) 247-253; DOI: https://doi.org/10.21873/invivo.11767

Main menu

User menu

Search

adverse events

Pages